SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Zealand Pharma Starts Phase 2 Trial of Obesity Drug Combination

Zealand Pharma announced the start of ZYNERGY, a Phase 2 dose-finding trial of petrelintide with enicepatide. The Roche-sponsored trial is expected to enroll 480 participants and assess weight change through week 40.

ZEAL

Story updates

06:05:05 AM UTC
SquawkNews
Zealand Pharma Announces Phase 2 Zynergy Trial Initiation Of Petrelintide With Enicepatide

Related stories